Open AccessPCSK9 and Cardiovascular Disease in Individuals with Moderately Decreased Kidney Function
Author(s) -
Azin Kheirkhah,
Claudia Lamina,
Barbara Kollerits,
Johanna F. SchachtlRiess,
Ulla T. Schultheiß,
Lukas Forer,
Peggy Sekula,
Fruzsina Kotsis,
KaiUwe Eckardt,
Florian Kronenberg
Publication year - 2022
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.01230122
Subject(s) - medicine , pcsk9 , renal function , disease , kidney disease , cardiology , cholesterol , ldl receptor , lipoprotein
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a key regulator of lipid homeostasis. Studies investigating the association between PCSK9 and cardiovascular disease in large cohorts of patients with CKD are limited.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom